Shopping Cart 0
Cart Subtotal
AED 0

Kiadis Pharma NV (KDS) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 1101

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 2202

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 3303

Details

Summary

Kiadis Pharma NV (Kiadis) is a biopharmaceutical company that develops and markets cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company offers cellular products including ATIR101 and ATIR201 for infusion. Its ATIR101 lowers the risks and limitations in blood cancers, cancer relapse, opportunistic infections, and limited donor availability. Kiadis develops ATIR201 for the treatment of thalassemia. Its product candidates are produced using the proprietary TH9402 compound which selectively targets and depletes rapidly dividing cells such as immune reactive cells in a mixed lymphocyte reaction between donor and patient material. The company uses theralux platform to develop therapeutic products. Its products serve the needs of patients suffering from hematological malignancies and blood cancer transplant. Kiadis is headquartered in Amsterdam, the Netherlands.

Kiadis Pharma NV Key Recent Developments

Mar 05,2019: Kiadis Pharma strengthens management team

Feb 04,2019: Kiadis Pharma appoints Dr. Robert Friesen as Chief Scientific Officer

Jan 04,2019: Kiadis Pharma expands presence in the United States

Nov 08,2018: Kiadis Pharma strengthens core team with three senior appointments

Sep 06,2018: Kiadis Pharma announces two senior management appointments

This comprehensive SWOT profile of Kiadis Pharma NV provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Kiadis Pharma NV including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

READ MORE

Table Of Content

Scope

Table of Contents

Section 1-About the Company

Kiadis Pharma NV-Key Information

Kiadis Pharma NV-Overview

Kiadis Pharma NV-Key Employees

Kiadis Pharma NV-Key Employee Biographies

Kiadis Pharma NV-Key Operational Heads

Kiadis Pharma NV-Major Products and Services

Kiadis Pharma NV-History

Kiadis Pharma NV-Company Statement

Kiadis Pharma NV-Locations And Subsidiaries

Kiadis Pharma NV-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Kiadis Pharma NV-Business Description

Kiadis Pharma NV-Corporate Strategy

Kiadis Pharma NV-SWOT Analysis

SWOT Analysis-Overview

Kiadis Pharma NV-Strengths

Kiadis Pharma NV-Weaknesses

Kiadis Pharma NV-Opportunities

Kiadis Pharma NV-Threats

Kiadis Pharma NV-Key Competitors

Section 3-Company Financial Performance Charts

Kiadis Pharma NV-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix

Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

Note*: Some sections may be missing if data is unavailable for the company


List Of Figure

List of Figures

Kiadis Pharma NV, Performance Chart

Kiadis Pharma NV, Ratio Charts


List Of Table

List of Tables

Kiadis Pharma NV, Key Information

Kiadis Pharma NV, Key Ratios

Kiadis Pharma NV, Share Data

Kiadis Pharma NV, Major Products and Services

Kiadis Pharma NV, History

Kiadis Pharma NV, Key Employees

Kiadis Pharma NV, Key Employee Biographies

Kiadis Pharma NV, Key Operational Heads

Kiadis Pharma NV, Other Locations

Kiadis Pharma NV, Subsidiaries

Kiadis Pharma NV, Key Manufacturing facilities

Kiadis Pharma NV, Key Competitors

Kiadis Pharma NV, SWOT Analysis

Kiadis Pharma NV, Ratios based on current share price

Kiadis Pharma NV, Annual Ratios

Kiadis Pharma NV, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Kiadis Pharma NV, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Company Profile

Company Profile Title

Summary

Kiadis Pharma NV (Kiadis) is a biopharmaceutical company that develops and markets cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company offers cellular products including ATIR101 and ATIR201 for infusion. Its ATIR101 lowers the risks and limitations in blood cancers, cancer relapse, opportunistic infections, and limited donor availability. Kiadis develops ATIR201 for the treatment of thalassemia. Its product candidates are produced using the proprietary TH9402 compound which selectively targets and depletes rapidly dividing cells such as immune reactive cells in a mixed lymphocyte reaction between donor and patient material. The company uses theralux platform to develop therapeutic products. Its products serve the needs of patients suffering from hematological malignancies and blood cancer transplant. Kiadis is headquartered in Amsterdam, the Netherlands.

Kiadis Pharma NV Key Recent Developments

Mar 05,2019: Kiadis Pharma strengthens management team

Feb 04,2019: Kiadis Pharma appoints Dr. Robert Friesen as Chief Scientific Officer

Jan 04,2019: Kiadis Pharma expands presence in the United States

Nov 08,2018: Kiadis Pharma strengthens core team with three senior appointments

Sep 06,2018: Kiadis Pharma announces two senior management appointments

This comprehensive SWOT profile of Kiadis Pharma NV provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Kiadis Pharma NV including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

READ MORE

Scope

Table of Contents

Section 1-About the Company

Kiadis Pharma NV-Key Information

Kiadis Pharma NV-Overview

Kiadis Pharma NV-Key Employees

Kiadis Pharma NV-Key Employee Biographies

Kiadis Pharma NV-Key Operational Heads

Kiadis Pharma NV-Major Products and Services

Kiadis Pharma NV-History

Kiadis Pharma NV-Company Statement

Kiadis Pharma NV-Locations And Subsidiaries

Kiadis Pharma NV-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Kiadis Pharma NV-Business Description

Kiadis Pharma NV-Corporate Strategy

Kiadis Pharma NV-SWOT Analysis

SWOT Analysis-Overview

Kiadis Pharma NV-Strengths

Kiadis Pharma NV-Weaknesses

Kiadis Pharma NV-Opportunities

Kiadis Pharma NV-Threats

Kiadis Pharma NV-Key Competitors

Section 3-Company Financial Performance Charts

Kiadis Pharma NV-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix

Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

Note*: Some sections may be missing if data is unavailable for the company


List Of Figure

List of Figures

Kiadis Pharma NV, Performance Chart

Kiadis Pharma NV, Ratio Charts


List Of Table

List of Tables

Kiadis Pharma NV, Key Information

Kiadis Pharma NV, Key Ratios

Kiadis Pharma NV, Share Data

Kiadis Pharma NV, Major Products and Services

Kiadis Pharma NV, History

Kiadis Pharma NV, Key Employees

Kiadis Pharma NV, Key Employee Biographies

Kiadis Pharma NV, Key Operational Heads

Kiadis Pharma NV, Other Locations

Kiadis Pharma NV, Subsidiaries

Kiadis Pharma NV, Key Manufacturing facilities

Kiadis Pharma NV, Key Competitors

Kiadis Pharma NV, SWOT Analysis

Kiadis Pharma NV, Ratios based on current share price

Kiadis Pharma NV, Annual Ratios

Kiadis Pharma NV, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Kiadis Pharma NV, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts